NCT07505966

Brief Summary

Title: CLEAR-CS Study - Active Chest Tube Clearance After Cardiac Surgery This study looks at two methods of removing blood and fluid from the chest after heart surgery. After cardiac operations, patients usually have chest tubes placed to drain blood and fluid. Sometimes these tubes get blocked, leading to retained blood inside the chest. This can cause complications such as the need for another surgery, heart compression, or longer hospital stays. The study compares patients who received active chest tube clearance, a method designed to keep the tubes open and remove blood continuously, with patients who received standard passive chest tube drainage. Researchers will review medical records from three heart surgery centers to see which method is associated with fewer complications, less bleeding, and shorter hospital stays. No additional procedures will be performed as part of this study. Purpose: To evaluate whether active chest tube clearance improves safety and outcomes after heart surgery compared to standard drainage. Who Can Participate: This study uses data from adult patients (18 years and older) who underwent heart surgery with chest tubes placed. No new patients will be enrolled. Duration of Participation: Data from the period 2022-2024 will be analyzed. Risks and Benefits: There is no direct risk to patients, as no new procedures are being performed. The study may help improve chest drainage practices and reduce complications for future patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

March 17, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 1, 2026

Completed
Last Updated

April 1, 2026

Status Verified

March 1, 2026

Enrollment Period

3 years

First QC Date

March 17, 2026

Last Update Submit

March 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of Retained Blood Syndrome (RBS) after cardiac surgery

    Composite outcome including reoperation for bleeding, cardiac tamponade requiring procedural intervention, hemothorax requiring additional drainage, or retained intrathoracic clot requiring procedural management. Data will be collected retrospectively from patient medical records.

    "From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"

Secondary Outcomes (8)

  • Reoperation for bleeding

    "From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"

  • Incidence of cardiac tamponade requiring procedural intervention

    "From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"

  • Incidence of hemothorax requiring additional drainage

    "From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"

  • Incidence of chest tube occlusion

    "From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"

  • Incidence of postoperative atrial fibrillation

    "From end of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first, assessed by review of patient medical records by trained research personnel"

  • +3 more secondary outcomes

Study Arms (2)

Active Chest Tube Clearance

Patients managed with active chest tube clearance techniques intended to maintain chest tube patency and facilitate continuous evacuation of postoperative blood. No additional interventions are applied beyond standard care.

Standard Passive Chest Tube Drainage

Patients managed with standard passive chest tube drainage following cardiac surgery. No additional interventions are applied beyond standard care.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients who underwent cardiac surgery with mediastinal chest tube placement at participating tertiary cardiac surgery centers. Data will be collected retrospectively from medical records; no direct patient contact occurs.

You may qualify if:

  • Adult patients (≥18 years) undergoing cardiac surgery via median sternotomy, including CABG, valve surgery, or combined procedures.
  • Placement of mediastinal chest tubes postoperatively

You may not qualify if:

  • Redo sternotomy
  • Surgery for acute aortic dissection
  • Heart transplantation
  • Mechanical circulatory support implantation
  • Incomplete or missing essential medical records
  • Intraoperative death

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Assiut University Faculty of Medicine

Asyut, Egypt

Location

Beni Suef University Faculty of Medicine

Banī Suwayf, Egypt

Location

Cairo University Hospital

Cairo, 02, Egypt

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate proffessor

Study Record Dates

First Submitted

March 17, 2026

First Posted

April 1, 2026

Study Start

January 1, 2022

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

April 1, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared with other researchers. The study involves retrospective analysis of de-identified patient data collected from institutional medical records. Data sharing is restricted due to institutional policies and confidentiality considerations.

Locations